Saffron: A potential drug-supplement for severe acute respiratory syndrome coronavirus (COVID) management

Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2 (COVID-19), came as a significant health care challenge for humans in 2019–20. Based on recent laboratory and epidemiological studies, a growing list of mutations in the virus has the potential to enhance its transmission or help it evade t...

Descripción completa

Detalles Bibliográficos
Autores principales: Husaini, Amjad M., Jan, Khan Nadiya, Wani, Gowher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118646/
https://www.ncbi.nlm.nih.gov/pubmed/34007917
http://dx.doi.org/10.1016/j.heliyon.2021.e07068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118646/
https://www.ncbi.nlm.nih.gov/pubmed/34007917
http://dx.doi.org/10.1016/j.heliyon.2021.e07068

Ejemplares similares